Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Palbociclib Combined With Fulvestrant in HR-Positive, HER2-Negative Metastatic Breast Cancer After Endocrine Failure
Category & Conditions: Cancer
Study Phase : 3
Medicine: Ibrance (palbociclib)
Language: English
ViewDownloadPrint
A Study Comparing Palbociclib Plus Letrozole Versus Placebo Plus Letrozole for the Treatment of Asian Postmenopausal Women with Advanced Breast Cancer
Category & Conditions: Cancer
Study Phase : 3
Medicine: Ibrance (palbociclib)
Language: English
ViewDownloadPrint
Study to Provide Access to Palbociclib and Letrozole For Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer That has Spread to Other Parts of the Body
Category & Conditions: Cancer
Study Phase : 3
Medicine: Ibrance (palbociclib)
Language: English
ViewDownloadPrint
Study of Palbociclib Combined With Chemotherapy in Pediatric Patients With Recurrent/Refractory Solid Tumors
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: Ibrance (palbociclib)
Language: English
ViewDownloadPrint
Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non-Small Cell Lung Cancer Patients in India
Category & Conditions: Cancer
Study Phase : 4
Medicine: Lorbrena (lorlatinib)
Language: English
ViewDownloadPrint
A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: Lorbrena (lorlatinib)
Language: English
ViewDownloadPrint
Study of Marstacimab in Men With Hemophilia
Category & Conditions: Rare Diseases
Study Phase : 2
Medicine: marstacimab (PF-06741086)
Language: English
ViewDownloadPrint
Study to Evaluate the Long‑Term Safety, Tolerability and Efficacy of Subcutaneous Marstacimab in Subjects With Severe Hemophilia
Category & Conditions: Rare Diseases
Study Phase : 2
Medicine: marstacimab (PF-06741086)
Language: English
ViewDownloadPrint
A Study to Learn About the Effects and Safety of Marstacimab (PF-06741086) in Teenagers and Adults with Severe Hemophilia A or Moderately Severe to Severe Hemophilia B With or Without Inhibitors
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: marstacimab (PF-06741086)
Language: English
ViewDownloadPrint
A study to test whether PF-05221304 and PF-06865571 caused any medical problems and if they were able to lower levels of liver fat when taken alone or together by patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Category & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: PF-05221304 + PF-06865571
Language: English
ViewDownloadPrint
Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis
Category & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: PF-05221304 + PF-06865571
Language: English
ViewDownloadPrint
A Study to Learn the Effects of Ervogastat (DGAT2i) Given Alone or Together with Clesacostat (ACCi), Compared to Placebo, in People With Non-alcoholic Steatohepatitis and Stage 2 or 3 Fibrosis
Category & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: PF-05221304 + PF-06865571
Language: English
ViewDownloadPrint